ReviewFrontiers in oncology2020

Synergies of Antiangiogenic Therapy and Immune Checkpoint Blockade in Renal Cell Carcinoma: From Theoretical Background to Clinical Reality.

Xiaohan Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.